AGTR1 and vascular smooth muscle hypertrophy: ATRAP interacts with the carboxy-terminus of AT1R and inhibits AT1R signaling pathways that produce detrimental pathological effects via blood pressure regulation, cardiac and vascular hypertrophy, and adipose tissue metabolism [17,18,19].